Pharmacotherapy for recently evacuated military casualties
Related Experiment Video
Updated: Nov 7, 2026

System for Focal, Closed-System Central Nervous System Injury
Published on: November 29, 2024
M J Friedman1, D S Charney, S M Southwick
1Department of Veterans Affairs National Center for PTSD, VAM&ROC, White River Junction, VT 05009.
Abstract:
In late 1990 during the massive Operation Desert Shield/Storm (ODS) deployment of United Nations troops, the VA/DoD Joint Contingency Plan was activated. Worst case scenarios projected tens of thousands of medical evacuees from the Persian Gulf and predicted that U.S. Military Communication Zone and CONUS bed capacity would quickly be saturated. As a result, a massive educational program was rapidly implemented to prepare 80 VA hospitals to receive ODS personnel within 1-3 weeks of their evacuation from battalion aid stations or other front-echelon medical facilities. This article was written as part of this educational effort. Noting that there were no published articles on pharmacotherapy for recently evacuated military casualties, the authors wrote the present manuscript for inclusion in the ODS Clinical Packet prepared by the VA's National Center for PTSD and circulated to VA mental health professionals. Since the published literature still lacks an article on this subject and since we believe that our comments on pharmacotherapy apply to survivors of most acute traumatic events, we present our observations and recommendations with the hope that they may be useful to military, VA, and civilian practitioners.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Pharmaceutical Poisoning: Treatment Strategies
Psychosis: Goals of Pharmacotherapy
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Post-traumatic Stress Disorder
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events, are a...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence